MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$36,478K
Free Cash flow
-$85,553K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of mark...
Change in fair value of notes pa...
Prepaid expenses and other curre...
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Other non-cash items, net
Purchases of property and equipm...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Acquisition of ipr&d asset
-
-
0
0
Net loss
-137,311
-130,532
-145,555
-173,443
Depreciation and amortization
2,259
2,366
2,573
3,125
Non-cash share-based compensation
19,164
28,286
16,952
21,535
Issuance of common shares as payment under license and other agreements
0
858
0
0
Obligation to issue common shares as payment for license agreements and other arrangements
-
-
0
-
Fair value of forward contract and derivative liabilities under license agreement
-
-
0
0
Change in fair value of forward contract and derivative liabilities
0
0
-20,700
11,274
Issuance of warrant under license agreement
-
-
0
0
Change in fair value of notes payable
14,638
3,012
3,690
-11,200
Other non-cash items, net
520
837
-5,583
1,162
Prepaid expenses and other current and non-current assets
-7,523
-12,564
-8,815
-6,497
Accounts payable
1,692
-1,221
-5,848
-2,137
Accrued expenses and other current and non-current liabilities
7,456
-64,414
-12,792
-7,371
Net cash used in operating activities
-85,099
-149,918
-130,662
-145,716
Proceeds from maturities of marketable securities
75,000
35,000
75,000
165,000
Proceeds from sales of marketable securities
-
-
0
-
Purchases of marketable securities
29,724
19,788
88,731
0
Purchases of property and equipment
454
0
8
13
Cash acquired from acquisition of ipr&d asset
-
-
0
-
Other investing activities
0
-
0
20
Net cash provided by investing activities
44,822
15,212
-13,739
164,967
Change in restricted cash due to former parent
-
-
0
-
Proceeds from issuance of notes payable
0
-
0
0
Proceeds from issuance of common shares
0
178,884
189,175
0
Payment of issuance costs
0
-
450
0
Proceeds from equity incentive plan
-
-
-
122
Proceeds from issuance of common shares under 2022 equity incentive plan
3,796
132
1,833
-
Other financing activities, net
0
0
-194
0
Net cash provided by financing activities
3,796
179,016
188,796
122
Effects of exchange rates on cash, cash equivalents, and restricted cash
3
16
0
14
Net increase in cash, cash equivalents, and restricted cash
-36,478
44,326
44,395
19,387
Cash, cash equivalents, and restricted cash at beginning of period
277,105
232,779
188,384
102,542
Cash, cash equivalents, and restricted cash at end of period
240,627
277,105
232,779
188,384
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of marketable...
$75,000K
(-77.27%↓ Y/Y)
Proceeds from issuance of
common shares under...
$3,796K
Net cash provided by
investing activities
$44,822K
(-69.99%↓ Y/Y)
Net cash provided by
financing activities
$3,796K
(-98.48%↓ Y/Y)
Effects of exchange
rates on cash, cash...
$3K
(117.65%↑ Y/Y)
Canceled cashflow
$30,178K
Net increase in
cash, cash...
-$36,478K
(-154.89%↓ Y/Y)
Canceled cashflow
$48,621K
Non-cash share-based
compensation
$19,164K
(-74.06%↓ Y/Y)
Change in fair value of
notes payable
$14,638K
(1330.08%↑ Y/Y)
Prepaid expenses and
other current and...
-$7,523K
(-163.86%↓ Y/Y)
Accrued expenses and
other current and...
$7,456K
(-69.41%↓ Y/Y)
Depreciation and
amortization
$2,259K
(-46.52%↓ Y/Y)
Accounts payable
$1,692K
(5.82%↑ Y/Y)
Purchases of marketable
securities
$29,724K
(-83.31%↓ Y/Y)
Purchases of property and
equipment
$454K
(-34.58%↓ Y/Y)
Net cash used in
operating activities
-$85,099K
(74.45%↑ Y/Y)
Canceled cashflow
$52,732K
Net loss
-$137,311K
(67.29%↑ Y/Y)
Other non-cash items,
net
$520K
(-87.76%↓ Y/Y)
Buy us a coffee
Biohaven Ltd. (BHVN)
Biohaven Ltd. (BHVN)